Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
65°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by XPhyto Therapeutics Corp.
XPhyto, Biosensors Market and Product Developments on Platform-Based Oral Dissolvable Biosensors for Oral Health and Infectious Disease
April 11, 2022
From
XPhyto Therapeutics Corp.
Via
AccessWire
Tickers
CSE:XPHY
XPHYF
XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH
December 06, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
COVID-19
Cannabis
Intellectual Property
Tickers
CSE:XPHY
XPHYF
XPhyto Therapeutics Announces Stock Option Grants
December 03, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Tickers
CSE:XPHY
XPHYF
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000
November 26, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Tickers
CSE:XPHY
XPHYF
XPhyto Announces CFO Appointment
November 19, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development
November 03, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Reports Development Update for its Drug Delivery Business
October 12, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Tickers
CSE:XPHY
XPHYF
Xphyto Announces Engagement of Consultants for Marketing and Promotional Activities
October 08, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Tickers
CSE:XPHY
XPHYF
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab
September 08, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Launches First Commercial Biosensor for Oral Disease
August 30, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto’s Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates
July 28, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio
July 20, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
COVID-19
Cannabis
Intellectual Property
Tickers
CSE:XPHY
XPHYF
XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.
July 02, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test
June 30, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
June 08, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Tickers
CSE:XPHY
XPHYF
XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany
May 20, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Provides Update on Drug Formulation and Development Business
May 13, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany
May 07, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
April 28, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test
April 21, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
XPhyto adds Top-Level Executive Talent to its Global Operations
April 20, 2021
From
XPhyto Therapeutics Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
Tickers
CSE:XPHY
XPHYF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.